EP1476447A1 - Composes cycliques et leur utilisation en tant que ligands complexes - Google Patents

Composes cycliques et leur utilisation en tant que ligands complexes

Info

Publication number
EP1476447A1
EP1476447A1 EP03702641A EP03702641A EP1476447A1 EP 1476447 A1 EP1476447 A1 EP 1476447A1 EP 03702641 A EP03702641 A EP 03702641A EP 03702641 A EP03702641 A EP 03702641A EP 1476447 A1 EP1476447 A1 EP 1476447A1
Authority
EP
European Patent Office
Prior art keywords
compound
compounds
cyclic
general formula
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03702641A
Other languages
German (de)
English (en)
Inventor
Erich Tauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP1476447A1 publication Critical patent/EP1476447A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings

Definitions

  • the present invention relates to cyclic compounds, processes for their preparation, their use as complex ligands and complexes containing them.
  • crown ethers can be used as multidental complexing agents. It is a class of planar macrocyclic polyethers. The oxygen atoms are often linked by ethylene bridges, with one or more benzene or cyclohexane rings being often fused on. The oxygen atoms of the crown ethers can also be partially or completely replaced by other heteroatoms such as nitrogen, phosphorus or sulfur. This gives, for example, aza, phosphate or thia crown ethers. There may also be polar groups which can assume the donor position.
  • crown ethers known to date do not have a consistently suitable property profile for all complexation tasks. There is therefore still a demand for cyclic complex ligands which show new property profiles.
  • the object of the present invention is to provide cyclic compounds which can preferably be used as complex ligands.
  • XYZ N CO 1 , R 2 , R 3 H, C 1-6 alkyl.
  • the radicals R, R 2 and R 3 can be chosen so that they do not hinder the cyclization reaction for the preparation of the compounds of the general formula (I).
  • the radicals are each independently hydrogen atoms or C 1-3 alkyl radicals, particularly preferably hydrogen atoms or methyl radicals, in particular hydrogen atoms.
  • cyclic compounds of the general formula (I) can be prepared by cyclization of compounds of the general formula (II)
  • R 4 -COOH or a derivative thereof, n are each 1 or 2, to obtain the stoichiometry, R 1, R 2, R 3 H, Ci- ö alkyl.
  • the radical R is a carboxylic acid radical or a derivative thereof.
  • the derivative is preferably an acid chloride, an ester, an amide or another corresponding carboxylic acid derivative.
  • Esters are preferably esters of lower alkanols such as C 1-4 alkanols.
  • Amides are preferably derived from ammonia or primary alkylamines.
  • the cyclization is preferably carried out by heating in polyphosphoric acid. As a rule, the process is carried out under a protective gas atmosphere (nitrogen).
  • the compounds of the general formula (III) are preferably prepared by photochemical reaction of smaller precursor compounds. This is explained in more detail below using a preferred connection.
  • the cyclic compounds of the general formulas (I) and (III) can be used for a large number of applications. They are preferably used as complex ligands.
  • the invention also relates to corresponding complexes containing a complexed metal ion and at least one cyclic compound of the general formulas (I) and (III) as complex ligands.
  • Preferred metal ions to be complexed are derived from alkali metals.
  • cyclic compounds according to the invention there may also be other ligands which are customary in the field of complex chemistry.
  • Compound (5) is in the form of a rigid and flat ring and is similar to a 16-crown-4 ether.
  • compound (8) resembles a porphyrin system.
  • the imidazoles are tautomeric, so that the hydrogen atom on nitrogen can change from position 1 to position 3 and back.
  • a metal atom in the center of the compound (8) can be bonded by 4, 3, 2 or a covalent bond or without covalent bond.
  • the most general process for the preparation of 2-R-benzoxazoles involves the condensation of a 2-aminophenol with a suitable carboxylic acid, acid chloride, ester, amide or other derivative of the carboxylic acid.
  • a suitable carboxylic acid acid chloride, ester, amide or other derivative of the carboxylic acid.
  • the amide (4) can be prepared from the precursor 2-hydroxy-3-nitrobenzamide (3).
  • the desired compound (5) can be obtained in acceptable yields.
  • the yield was 32%, the compound forming colorless crystals with an unexpectedly high melting point of 520 ° C.
  • the substance is very slightly soluble in all organic solvents.
  • the compound has the expected UV spectrum, with a maximum for the long wavelengths at 364 n in CHC1 3 .
  • cyclo-2,4 ': 2, 7 "2"4'":2"', 7-quaterbenzimidazol (8) can be carried out in a manner similar to the preparation of (5).
  • 2-amino-3-nitrobenzoic acid (6) in dilute ammonia can be catalytically reduced with H 2 / Pd, an ammonium salt of 2,3-diaminobenzoic acid (7) being obtained.
  • This acid (7) can then be heated in polyphosphoric acid to obtain the cyclic compound (8).
  • An unoptimized yield of 14.5% was found for the special compound (8).
  • the compound (8) forms a yellow microcrystalline powder, the one still has lower solubility in organic solvents than the compound (5).
  • the compound (8) can be sublimed at 630 ° C. and 6 ⁇ 10 "3 hPa. At normal pressure under nitrogen, the compound changes color from yellow to brown at a temperature between 700 ° C. and 750 ° C. This results in partial sublimation, however no melting was observed.
  • the 1 H-NMR spectrum permits the unambiguous assignment of the aromatic protons which correspond to structure (8).
  • the maximum for long wavelengths in the UV-vis spectrum is 393 nm (in DMSO) for the compound (8).
  • Benzoxazole can be symmetrically photodehydrodimerized to form 2,2 'dibenzoxacolyl. This reaction takes place during irradiation in aerated polar solvents.
  • 7,7 ': T, 2 ": 7", 7 "' - quaterbenzoxazole (13) can be prepared by irradiating a solution of (12) in methanol with light of a wavelength of 245 nm Solution in the form of colorless crystals with analytical purity.
  • the solubility of compound (13) in methanol, ethanol and acetonitrile is ⁇ 10 " mol / 1.
  • An improved solubility is given in chloroform and dimethylformamide.
  • the synthesis of the compound (5) described above allows the individual benzoxazole units to be connected between positions 2 and 7.
  • Isomeric molecules in the form of the compound (5) can also be prepared by appropriate synthetic methods using different starting materials or more units are connected between positions 2 and 4. As a result, the nitrogen atoms are directed towards the center of the molecule.
  • the compounds (5) and (13) can also be replaced by corresponding compounds in which the benzoxazole units have been replaced by other benzo-x-azoles (8).
  • UV Perkin-Elmer model 320
  • the compound (2) used can be prepared from the free acid, as described in J. Het. Chem. 1971, 8, pages 989 to 91. At this point, both the preparation of esters and amides are described. It also describes how the nitro compound can be converted into the amino compound. Thus, other possible analogs of compounds (2), (3) and (4) are also described in this reference.
  • the product was sublimed by sublimation at 630 ° C and 6 x 10 "3 hPa to obtain a yellow-green product.
  • the substance slowly darkened at a temperature between 700 and 750 ° C without melting (when heated under nitrogen and at normal pressure), the process was accompanied by partial sublimation.
  • UV (DMSO): ⁇ max (lg ⁇ ) 393 nm (3.99), 372s (4.24), 356s (4.78), 349 (4.82), 340 (4.87),
  • 2-Amino-3-nitrobenzoic acid can be prepared as described in J. Med. Chem. 1990, 33, pages 814 to 819. This document also describes the further conversion to substituted benzimidazoles, see the reaction schemes on page 815. Substituted 2,3-diaminobenzoic acids are described on page 816 in Scheme II. Possible substituents are also mentioned in Table II, so that this document also describes the preparation of similar, substituted compounds.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'invention concerne des composés cycliques de formule (I), dans laquelle: X-Y-Z représentent N=C-O, NH-C=N, N=C-NH et R1, R2, R3 représentent H, alkyle C1-6, et de formule générale (III), dans laquelle : X-Y-Z représentent N=C-O et R1,R2,R3 représentent H, alkyle C1-6, lesquels peuvent être utilisés comme ligands de complexes.
EP03702641A 2002-02-15 2003-02-14 Composes cycliques et leur utilisation en tant que ligands complexes Withdrawn EP1476447A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10206366A DE10206366A1 (de) 2002-02-15 2002-02-15 Cyclische Verbindungen und ihre Verwendung als Komplexliganden
DE10206366 2002-02-15
PCT/EP2003/001490 WO2003068779A1 (fr) 2002-02-15 2003-02-14 Composes cycliques et leur utilisation en tant que ligands complexes

Publications (1)

Publication Number Publication Date
EP1476447A1 true EP1476447A1 (fr) 2004-11-17

Family

ID=27634999

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03702641A Withdrawn EP1476447A1 (fr) 2002-02-15 2003-02-14 Composes cycliques et leur utilisation en tant que ligands complexes

Country Status (6)

Country Link
US (1) US20050159596A1 (fr)
EP (1) EP1476447A1 (fr)
JP (1) JP2005525343A (fr)
AU (1) AU2003205767A1 (fr)
DE (1) DE10206366A1 (fr)
WO (1) WO2003068779A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10214937A1 (de) * 2002-04-04 2003-10-16 Basf Ag Cyclische Verbindungen und ihre Verwendung als Lichtabsorber, Lichtemitter oder Komplexliganden
FI20040592A (fi) 2004-04-27 2005-10-28 Imbera Electronics Oy Lämmön johtaminen upotetusta komponentista

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH476793A (de) * 1964-09-01 1969-08-15 Ciba Geigy Verwendung von neuen Bis-azolen als optische Aufhellmittel ausserhalb der Textilindustrie
US3481945A (en) * 1966-12-09 1969-12-02 Moleculon Corp Tetrabenzimidazole
US5180821A (en) * 1990-01-16 1993-01-19 Moleculon Research Company Cyclic tetrabenzimidazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03068779A1 *

Also Published As

Publication number Publication date
US20050159596A1 (en) 2005-07-21
AU2003205767A1 (en) 2003-09-04
WO2003068779A1 (fr) 2003-08-21
DE10206366A1 (de) 2003-08-28
JP2005525343A (ja) 2005-08-25

Similar Documents

Publication Publication Date Title
DE2723209A1 (de) Tetracyclische pyridin- oder pyrrolderivate
WO1994007862A1 (fr) Nouveaux bis-naphtalamides substitues asymetriquement
DE2141616C3 (de) Oxazole- und Oxazine eckige Klammer auf 3,2-c eckige Klammer zu chinazolinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2248477A1 (de) Imidazolinverbindungen
DE2846321C2 (fr)
DE3784795T2 (de) Verfahren zur herstellung von 5,6-substituierten-2,4-chinazolindiaminen und zwischenprodukten.
WO2003068779A1 (fr) Composes cycliques et leur utilisation en tant que ligands complexes
CH637961A5 (de) Tricyclische chinazoline und verfahren zu ihrer herstellung.
EP0290003A2 (fr) Imidazoles
DE69127714T2 (de) Synthese und Bestimmung von Azamitosen und Iminoazamitosen
DE2042758A1 (de) Verfahren zur Herstellung von Benzodiazepinderivaten
DE19830040B4 (de) Neue Cyclopentadiquinoxalin-Derivate
EP0873315B1 (fr) Derives de phenanthridine, procedes permettant de les preparer et medicaments contenant des phenanthridines
EP0393499A1 (fr) Procédé pour la préparation de carbovir et produits intermédiaires à cet effet
EP0117467B1 (fr) Bisamidines polycycliques, leur procédé de préparation et leur application comme chimiothérapeutiques
AT250338B (de) Verfahren zur Herstellung neuer, basischer Derivate von substituierten Benzofuran-2-carbonsäuren und deren Salzen
EP0983247B1 (fr) Procede de production de bisimides aromatiques
EP0040685A2 (fr) Dérivés de l'acide lysergique et leurs compositions pharmaceutiques
DE1545759C3 (de) Vincaleukoblastin-derivate und ein Verfahren zu ihrer Herstellung
AT336031B (de) Verfahren zur herstellung von neuen naphthyridinderivaten und von deren saureadditionssalzen
DE1695757C3 (de) Pyridinmethanolcarbamate und Verfahren zu deren Herstellung
EP0492254A1 (fr) N-(tert-Butoxycarbonyl)maléimide
DE102011089353A1 (de) Verfahren zur Herstellung von Tetrahydrotetraazapentacenen und Derivaten
DE2334562A1 (de) Basisch substituierte benzol-1,3-disulfonamide und verfahren zu ihrer herstellung
DE2802757A1 (de) Benz eckige klammer auf cd eckige klammer zu indolyl-derivate, ihre verwendung und herstellung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040915

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 263/62 20060101ALI20061020BHEP

Ipc: C07D 487/22 20060101ALI20061020BHEP

Ipc: C07D 498/22 20060101AFI20061020BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070316